Curcumin
Curcumin, the yellow pigment in turmeric, has modest and mostly low-certainty evidence for knee-osteoarthritis pain and post-exercise soreness, small effects on blood sugar in people who already have prediabetes or diabetes, and nothing to show as a longevity drug. Much of its fame comes from cell studies that don't translate, and turmeric supplements, especially the capsules engineered to get it into your blood, carry a rare, unpredictable risk of liver injury.
If you want to try it for knee pain or for soreness after hard training, buy an independently tested product, take the dose studied for that formulation with a fatty meal, and stop at once at the first sign of liver trouble. Don't take it as an anti-aging supplement, and check with your prescriber first if you take other medicines.
Why it sounds better than it is
In cells and animals, curcumin touches almost every fashionable longevity pathway at once: it activates the energy sensor AMPK (the one switched on by exercise and fasting), inhibits the growth pathway mTOR, and damps inflammatory signalling. That breadth is exactly why it is oversold: the human trials are narrower, the effects are modest, and they are concentrated in people who are already ill.
Pooled, the human evidence is weak: a 2025 umbrella review of 25 curcumin meta-analyses found that about four in five of the 122 outcomes it graded rested on low- or very-low-certainty evidence, though the authors still judged curcumin safe and beneficial for several outcomes.[1]
Joints and training: the uses that hold up best
Knee osteoarthritis is curcumin's best-supported use, and even there the evidence is weak to moderate. Pooled trials consistently find that it relieves knee pain better than placebo, and in the few trials that compared it head-to-head with a non-steroidal anti-inflammatory drug (NSAID) such as ibuprofen or diclofenac, it did about as well.[2] One pooled analysis put the pain reduction at about 1.8 points on a 0–10 scale versus placebo. Side effects were no more common than with placebo and somewhat less common than with NSAIDs, though that difference could have been chance; most were digestive complaints such as bloating, reflux, indigestion or nausea.[3]
The trials are mostly short, small and often industry-funded, with signs that unfavourable results went unpublished, and an independent appraisal rated the reviews' methods extremely low quality.[4] "Comparable to an NSAID for mild-to-moderate knee osteoarthritis" is the honest ceiling. Curcumin is also not the best joint supplement: a 2025 network meta-analysis of 39 trials ranked Boswellia above it for pain and stiffness.[5]
The form may matter. Some pooled analyses found that only the enhanced-absorption products clearly beat placebo while plain curcumin extracts did not, but another found all forms helped, and no trial has compared formulations head-to-head.[6][7]
Exercise recovery: modest, and only clearly after deliberately damaging workouts. Curcumin does not make you fitter: it does not raise maximal oxygen uptake (VO₂ max), aerobic capacity or strength. In studies that deliberately cause muscle damage, it modestly blunts the soreness afterwards. A meta-analysis of 14 trials (349 people) found soreness about 0.6 points lower on pain scales, along with lower muscle-damage markers, over the following one to three days. The biggest soreness reduction, about 1.2 points, came at four days, though that rests on only 5 small studies and the trials disagreed a lot.[8] In athletes during their normal training, the results are mixed and the certainty is rated very low.[9] Possibly useful through a heavy training block; not a performance aid.
Blood sugar, fats and the liver: small effects in people who are already ill
Blood sugar improves a little, in people with prediabetes or type 2 diabetes. A meta-analysis of 34 trials in that group found fasting glucose about 0.6 mmol/L (about 10 mg/dL) lower and glycated haemoglobin (HbA1c, a marker of average blood sugar) about 0.3 percentage points lower, with better insulin sensitivity. The trials disagreed a lot, so the authors rate the evidence as low certainty, and they describe curcumin as an add-on to diabetes treatment, not a replacement.[10] In the same population, systolic blood pressure fell about 2.7 mmHg, more in people already hypertensive; diastolic pressure did not change significantly.[11]
In healthy people the evidence is thinner: in one small 12-week trial in 39 adults aged 45–74, an enhanced-absorption product (about 400 mg of curcumin a day) made blood vessels work better but did not change arterial stiffness or inflammation markers.[12]
Blood fats improve slightly. An early meta-analysis of five small trials found no change,[13] but a 2025 review that re-pooled 72 trials, mostly in people with chronic conditions such as diabetes, found LDL cholesterol and triglycerides each about 0.15 mmol/L lower, with larger effects in type 2 diabetes and widely varying trials.[14] It is not a substitute for lipid-lowering drugs.
Fatty liver: weak to moderate evidence. In small, short trials in people with fatty liver disease, curcumin modestly lowered liver enzymes in one meta-analysis,[15] did not in another,[16] and reduced liver fat in a third.[17] Given the separate liver-injury risk below, anyone with liver disease should use it only with their doctor.
Inflammation markers: a small average effect, not a reliable one. Two umbrella reviews found curcumin lowers C-reactive protein (a general blood marker of inflammation) and other inflammation markers a little on average,[18][19] but the trials are small and short and often disagree, and a meta-analysis in chronic inflammatory disease found no significant effect on any of them.[20]
Brain and mood: interesting, unproven
Memory. The headline trial gave 40 adults aged 51–84 without dementia a nanoparticle curcumin (180 mg a day) for 18 months and reported better memory, though the benefit only just reached statistical significance. Brain scans in 30 of them, using a non-standard tracer, showed no clear reduction in the amyloid and tau signal linked to Alzheimer's disease.[21] About ten small trials (roughly 500 people) have since been pooled, and the two meta-analyses disagree: one found no effect on overall thinking, and more side effects on curcumin;[22] the other found a benefit only in trials lasting at least 24 weeks, in people aged 60 or over, or in Asian participants.[23] Not established.
Depression and anxiety. A 2026 meta-analysis of 19 trials in adults with depression or depressive symptoms found a moderate improvement in depression scores, but the trials disagreed enormously and the authors call the result fragile.[24] The clearest signal is for curcumin as an add-on to antidepressants; on its own, compared with antidepressants, its effect was uncertain.[25] One anxiety meta-analysis reported a larger but similarly inconsistent effect.[26] The trials are small and short (6–12 weeks), and several are open-label. Not a treatment.
Why most curcumin never reaches your blood
Plain curcumin is almost useless taken by mouth. It barely dissolves in water and degrades in the gut, and what little is absorbed is quickly converted by the liver into bound forms that, in laboratory tests, have a fraction of curcumin's activity or almost none.[27] A typical Indian diet, about 2–2.5 g of turmeric a day, delivers only about 60–100 mg of curcumin, with negligible absorption.[28] So every clinical product is engineered to get around this:
| Approach | Example | What it does |
|---|---|---|
| Piperine (black-pepper extract) | Curcumin + piperine | Meant to block the enzymes that break curcumin down. A small 1998 study co-authored by a piperine maker reported a ~20-fold rise in blood levels in the first hour,[29] but a small 2025 independent study in 9 healthy men found it added nothing.[30] It may also strengthen drug interactions |
| Phytosome (lipid complex) | Meriva | Bound to phosphatidylcholine for better solubility; the form behind much of the joint and recovery data |
| Nanoparticle / colloidal | Theracurmin | Sub-micron particles; the form used in the memory trial, at low doses |
| Essential-oil complex | BCM-95 | Reconstituted with turmeric oils; ~7-fold higher absorption than raw powder |
Even the best of these leave a gap. That independent study of three commercial products found that the active, unbound form of curcumin stayed below 2 nM in most cases; the best product peaked at 6.7–38 nM, still roughly 100-fold below the concentrations used in the cell studies behind curcumin's celebrated mechanisms.[31] Vendor claims such as "65×" or "185× greater bioavailability" typically come from studies authored or financed by the makers. The practical consequence: a dose means nothing without its formulation, and turmeric powder or curry never reaches trial blood levels.
The catch: a rare, unpredictable liver injury
Turmeric liver injury is the most important thing to know before taking a supplement. The US National Institutes of Health's LiverTox database classifies turmeric and curcumin as a well-documented cause of liver injury and, in the US, what appears to have become the most common cause of liver injury from a herbal supplement. Most cases involve high-absorption products, but cases also occur with plain turmeric powder and even turmeric teas. It is probably very rare (roughly 1 in 10,000 to 1 in 100,000 people exposed, though the true rate is unknown),[32] and Health Canada, Italy, France and Australia have now added warnings or safety alerts for these supplements.[33]
What makes it hard to manage is that it is an immune reaction, not an overdose. Health Canada describes the risk as not dependent on dose or duration,[34] and a 2024 Spanish case involved only 120 mg of curcumin a day (with black pepper) for two months.[35] In the defining US case series of 10 patients, onset came 1–4 months in, one died, and 7 carried the immune-gene variant HLA-B*35:01,[36] the strongest known risk marker.[37] It usually clears within 1–3 months of stopping, but acute liver failure, transplants and deaths have occurred, mostly when people kept taking the product after symptoms began; LiverTox estimates that about 1 in 10 people who develop jaundice might die. Never take turmeric or curcumin again after a reaction, because a second exposure can bring it back worse.[38] Injury can also be silent: in one small series of biopsied cases, about half the patients had no symptoms and were found only on blood tests.[39]
That is not a reason to fear turmeric used as a spice in normal amounts. It is a reason to treat any turmeric or curcumin supplement as an active product rather than a harmless botanical, and not to assume that a short course or a low dose protects you.
Drug interactions
Curcumin can change how your body handles other drugs, unpredictably. In rats it altered a key drug-metabolising enzyme,[40] yet a short study in 8 healthy volunteers, co-authored by the product's maker, found no change in that enzyme (CYP3A4, which handles roughly half of all prescription drugs) with a high-dose curcumin-plus-piperine product.[41] In 12 volunteers, 300 mg a day cut levels of the test drug talinolol by about a third,[42] while 2 g of curcumin roughly tripled blood levels of sulfasalazine, a bowel and arthritis drug.[43] Together with curcumin's own mild blood-thinning and glucose-lowering effects, that makes these combinations worth taking seriously:
- Anticoagulants and antiplatelets (warfarin, clopidogrel, aspirin, NSAIDs): additive bleeding risk.
- Glucose-lowering drugs (metformin, insulin, SGLT2 inhibitors): additive risk of low blood sugar.
- Statins: no human study has shown that curcumin changes statin levels, but an interaction is possible; tell your prescriber if you develop muscle aches. A 2017 paper proposing curcumin as an add-on for statin muscle symptoms is an untested hypothesis.[44]
- Cancer drugs and immunosuppressants (including transplant drugs): not without specialist oversight. In women taking tamoxifen for breast cancer, high-dose curcumin lowered levels of the drug's active form by about 8% on its own (not statistically significant) and about 12% with piperine, which the researchers warned could push some patients below the effective level.[45] One transplant patient had a dangerously high level of tacrolimus, with kidney injury, after heavy turmeric use in food,[46] while a deliberate four-day test of 10 g of turmeric a day in another patient showed no change.[47]
If you take any of these, don't start any turmeric or curcumin supplement without checking with the prescriber.
How to buy and take it
- Pick a use case first. Knee-osteoarthritis pain and soreness after hard or unaccustomed training are the defensible reasons. For general anti-aging, the human evidence doesn't justify it.
- Match the dose to the formulation. These are the doses studied, not proven equivalents: phytosome (e.g. Meriva) about 1,000 mg a day split in two, for joints and recovery; nanoparticle (e.g. Theracurmin) about 90–180 mg a day; standard curcumin with piperine 1,000–1,500 mg a day with 10–20 mg of piperine, though piperine may give no absorption benefit and may raise the interaction risk. Commonly suggested supplement doses (500–1,000 mg of curcuminoids a day) run two to five times above the official acceptable daily intake (about 210 mg for a 70-kg adult),[48] and French and German food-safety agencies warn that limit may not cover enhanced-absorption products.[49][50]
- Take it with a fatty meal. Curcumin is fat-soluble, and absorption is much higher with dietary fat.
- Buy on verified quality, not label claims. Products often hold far less than labelled, and a review of data from six continents put turmeric adulteration around 20%, in supplements often synthetic curcumin sold as turmeric extract.[51] Choose products with independent verification (USP, NSF or other third-party testing).
- Loose spice is a different problem. Lead chromate, added to brighten turmeric's colour, is still found in parts of South Asia: a 2021–2023 survey of eastern India found 30% of samples above the legal lead limit,[52] and Bangladesh largely eliminated it only after a campaign combining publicity with enforcement.[53] It affects bulk spice, not standardised capsules.
- Watch for liver symptoms, whatever the course length. Avoid open-ended daily use, but don't treat 8–12 weeks as safe: most reactions start 1–4 months in. Stop at once and see a doctor with unexplained fatigue, nausea, poor appetite, stomach pain, dark urine or yellowing of the eyes or skin. If you have liver enzymes checked, do it before starting and in the first few months. See Midlife labs.
Who should skip it
Skip turmeric and curcumin supplements if you have gallbladder or bile-duct problems (including gallstones), are pregnant (supplements may be unsafe in pregnancy) or breastfeeding (safety above food amounts is unknown), take anticoagulants or are about to have surgery, or take diabetes medication without supervision.[54][55] Check with a doctor first if you have current or past liver problems or take other medications.
What it doesn't do
- It isn't a geroprotector. The "caloric-restriction mimic that slows aging" framing is mechanism dressed up as outcome. The pathway effects come almost entirely from cells, yeast, flies and rodents, and a landmark medicinal-chemistry review judged curcumin's test-tube activity largely artifact, making it "a highly improbable lead";[56] and one of the field's most prolific researchers had 18 papers retracted.[57] Crucially, no human trial shows curcumin extends life or slows aging, and the same is true of the broader "longevity stack" it is sold alongside (NMN, resveratrol and the rest).
- It doesn't reverse your epigenetic age. The widely shared "3 years younger" claim comes from an 8-week pilot trial in about 40 healthy men of a whole programme: diet, sleep and exercise advice, a greens powder and a probiotic. Turmeric was one of six optional foods (half a teaspoon), no curcumin supplement was given, and the clock used can differ by several years between repeat measurements of the same sample.[58][59]
- It doesn't treat cancer. The US National Cancer Institute considers the evidence inadequate to recommend it, and a systematic review of the few qualifying trials found no improvement in overall or progression-free survival.[60]
- It hasn't been shown to protect bones. The bone-density benefits are essentially all from rodents.
Further reading
- Zeng L et al. Efficacy and Safety of Curcumin and Curcuma longa Extract in the Treatment of Arthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. 2022.[61]
- Bahari H et al. Curcumin/Turmeric Supplementation on Glycemic Control in Adults With Prediabetes and Type 2 Diabetes: A Systematic Review and Dose–Response Meta-Analysis. 2026.[62]
- Xu Q et al. Curcumin and multiple health outcomes: critical umbrella review of intervention meta-analyses. 2025.[63]
- Turmeric. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. NIH/NCBI Bookshelf.[64]
- Halegoua-DeMarzio D et al. Liver Injury Associated with Turmeric — a Growing Problem: Ten Cases from the Drug-Induced Liver Injury Network. Am J Med 2023.[65]
- Turmeric: Usefulness and Safety. National Center for Complementary and Integrative Health, 2025.[66]
- Kroon MAGM et al. A pharmacokinetic study and critical reappraisal of curcumin formulations enhancing bioavailability. iScience 2025.[67]
- Darmonkow A et al. Advancements in curcuminoid formulations: an update on bioavailability enhancement strategies. Open Life Sci 2025.[68]
- Nelson KM et al. The Essential Medicinal Chemistry of Curcumin. J Med Chem 2017.[69]
- Naghsh N et al. Profiling Inflammatory Biomarkers following Curcumin Supplementation: An Umbrella Meta-Analysis. Evid Based Complement Alternat Med 2023.[70]
- Gafner S et al. A scoping review of turmeric adulteration based on data from six continents. Pharm Biol 2026.[71]